These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24697172)
1. Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration. Wang F; Cao J; Hao J; Liu K J Microencapsul; 2014; 31(4):382-9. PubMed ID: 24697172 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, bioavailability and tissue distribution of geniposide following intravenous and peroral administration to rats. Wang F; Cao J; Hao J; Liu K Biopharm Drug Dispos; 2014 Mar; 35(2):97-103. PubMed ID: 24122743 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565 [TBL] [Abstract][Full Text] [Related]
4. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability. Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336 [TBL] [Abstract][Full Text] [Related]
5. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. Varshosaz J; Minayian M; Moazen E J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503 [TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel. Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431 [TBL] [Abstract][Full Text] [Related]
8. Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation. B A; D N; Veerabrahma K Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):126-137. PubMed ID: 28290712 [TBL] [Abstract][Full Text] [Related]
9. Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel. Pandita D; Ahuja A; Lather V; Benjamin B; Dutta T; Velpandian T; Khar RK AAPS PharmSciTech; 2011 Jun; 12(2):712-22. PubMed ID: 21637945 [TBL] [Abstract][Full Text] [Related]
10. Effects of intestinal microbiota on the bioavailability of geniposide in rats. Jin MJ; Kim IS; Kim DH; Yoo HH J Agric Food Chem; 2014 Oct; 62(40):9632-6. PubMed ID: 25257195 [TBL] [Abstract][Full Text] [Related]
11. Comparative oral bioavailability of geniposide following oral administration of geniposide, Gardenia jasminoides Ellis fruits extracts and Gardenia herbal formulation in rats. Cheng S; Lin LC; Lin CH; Tsai TH J Pharm Pharmacol; 2014 May; 66(5):705-12. PubMed ID: 24325786 [TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Harde H; Das M; Jain S Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007 [TBL] [Abstract][Full Text] [Related]
13. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Chen CC; Tsai TH; Huang ZR; Fang JY Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469 [TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543 [TBL] [Abstract][Full Text] [Related]
15. Improved Oral Bioavailability and Liver Targeting of Sorafenib Solid Lipid Nanoparticles in Rats. Wang H; Wang H; Yang W; Yu M; Sun S; Xie B AAPS PharmSciTech; 2018 Feb; 19(2):761-768. PubMed ID: 28983849 [TBL] [Abstract][Full Text] [Related]
16. Development of levosulpiride-loaded solid lipid nanoparticles and their Khaleeq N; Din FU; Khan AS; Rabia S; Dar J; Khan GM J Microencapsul; 2020 Mar; 37(2):160-169. PubMed ID: 31916886 [TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. Hu L; Tang X; Cui F J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759 [TBL] [Abstract][Full Text] [Related]
18. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Wang W; Zhu R; Xie Q; Li A; Xiao Y; Li K; Liu H; Cui D; Chen Y; Wang S Int J Nanomedicine; 2012; 7():3667-77. PubMed ID: 22888226 [TBL] [Abstract][Full Text] [Related]
19. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles. Kumar M; Sharma G; Singla D; Singh S; Kakkar V; Gulati JS; Kaur IP Pharm Nanotechnol; 2020; 8(6):495-510. PubMed ID: 33115399 [TBL] [Abstract][Full Text] [Related]
20. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Kakkar V; Singh S; Singla D; Kaur IP Mol Nutr Food Res; 2011 Mar; 55(3):495-503. PubMed ID: 20938993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]